APA引用形式

Wainberg, M., Anstett, K., Mesplede, T., Quashie, P., Han, Y., & Oliveira, M. (2014). The R263K mutation in HIV integrase that is selected by dolutegravir may actually prevent clinically relevant resistance to this compound. J Int AIDS Soc.

シカゴスタイル引用形

Wainberg, Mark, Kaitlin Anstett, Thibault Mesplede, Peter Quashie, Yingshan Han, , Maureen Oliveira. "The R263K Mutation in HIV Integrase That Is Selected By Dolutegravir May Actually Prevent Clinically Relevant Resistance to This Compound." J Int AIDS Soc 2014.

MLA引用形式

Wainberg, Mark, et al. "The R263K Mutation in HIV Integrase That Is Selected By Dolutegravir May Actually Prevent Clinically Relevant Resistance to This Compound." J Int AIDS Soc 2014.